The association between the number of symptoms and the severity of Post-COVID-Fatigue after SARS-CoV-2 infection treated in an outpatient setting. — CFSMEATLAS
E2 ModerateModerate confidencePEM not requiredCross-SectionalPeer-reviewedMachine draft
Standard · 3 min
The association between the number of symptoms and the severity of Post-COVID-Fatigue after SARS-CoV-2 infection treated in an outpatient setting.
Schmidbauer, Lena, Kirchberger, Inge, Goßlau, Yvonne et al. · Journal of neurology · 2023 · DOI
Quick Summary
This study looked at 425 people who had mild-to-moderate COVID-19 treated as outpatients and followed them for about 8 months afterward. Researchers found that 37% of these people developed long-lasting fatigue (Post-COVID-Fatigue), and those who had more symptoms during their initial infection and ongoing symptoms were more likely to experience severe fatigue. The more symptoms someone had, the worse their fatigue tended to be.
Why It Matters
This study is significant because it shifts focus from severe COVID-19 hospitalizations to outpatient populations, demonstrating that long-term fatigue affects a substantial proportion of even mildly-infected individuals. Understanding the symptom burden relationship to fatigue severity may help identify high-risk patients early and inform mechanistic research into post-viral fatigue conditions like ME/CFS.
Observed Findings
37% of 425 outpatients developed Post-COVID-Fatigue approximately 249 days after mild-to-moderate COVID-19 infection.
Patients with PCF had significantly higher median symptom counts during both acute infection and persistent symptom phases compared to non-PCF patients.
Each additional acute symptom was associated with a 0.48-point increase in fatigue severity score; each additional persistent symptom was associated with a 1.18-point increase.
Symptoms most strongly associated with PCF severity were difficulty concentrating, memory problems, dyspnea on exertion, palpitations, and movement coordination problems.
70% of PCF cases occurred in women.
Inferred Conclusions
Symptom burden during acute COVID-19 and in the persistent phase are both independent predictors of Post-COVID-Fatigue severity.
Cognitive symptoms, respiratory symptoms, cardiac symptoms, and coordination problems during acute infection may serve as early risk indicators for developing severe long-term fatigue.
Even mild-to-moderate COVID-19 treated in outpatient settings carries substantial risk for post-viral fatigue in a significant subset of patients.
Remaining Questions
What are the biological mechanisms linking acute symptom burden and persistent fatigue severity?
What This Study Does Not Prove
This cross-sectional design cannot establish causation—we cannot determine whether having more symptoms causes worse fatigue or whether both result from an underlying biological process. The study does not identify the biological mechanisms of Post-COVID-Fatigue. Additionally, the predominantly female sample (70%) limits generalizability to men.
Tags
Symptom:Cognitive DysfunctionFatigue
Phenotype:Infection-TriggeredLong COVID Overlap
Method Flag:PEM Not DefinedNo ControlsMixed Cohort
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Why do women show higher rates of Post-COVID-Fatigue, and are the mechanisms gender-specific?
What is the natural history of Post-COVID-Fatigue beyond 249 days—do symptoms and fatigue severity improve, stabilize, or worsen over longer follow-up?
Are specific symptom patterns or combinations more predictive of severe fatigue than symptom count alone?